Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

e-Poster Display Session

6P - Role of inflammatory cytokines in distant metastasis of non-small cell lung cancer

Date

09 Dec 2020

Session

e-Poster Display Session

Presenters

Olga Savelieva

Citation

Annals of Oncology (2020) 31 (suppl_7): S1417-S1424. 10.1016/annonc/annonc389

Authors

O.E. Savelieva1, D. Pismenny2, L. Tashireva2, M. Zavyalova2, V. Perelmuter2

Author affiliations

  • 1 Department Of General And Molecular Oncology, Cancer Research Institute - Tomsk National Research Medical Center, Tomsk/RU
  • 2 Cancer Research Institute - Tomsk National Research Medical Center, Tomsk/RU
More

Abstract 6P

Background

Inflammation is an essential component of the tumor microenvironment. Cytokines involved in inflammation can also promote the formation of premetastatic niches and distant metastases (according to D. Layden's theory). The aim of this study was to identify which cytokines are associated with the distant metastases in NSCLC.

Methods

The prospective study included 35 patients, male – 27 (77 %), female – 8 (23 %) with T1–4N0–2M0 non-small cell lung cancer (NSCLC) treated at Cancer Research Institute, Tomsk National Research Medical Center. Seventeen (49 %) of the 35 patients received 2–3 courses of neoadjuvant chemotherapy (NACT). The concentration of IL-1b, IL-2, IL-4, IL-6, IL-10, IL-12, IL-17a, IL-33, TNFa, IFNg, CXCL-8 (IL-8), CCL-2 (MCP-1), CCL-5 (RANTES), CXCL-12 (SDF-1) and VEGFA was determined in the serum by the Luminex xMAP technology in accordance with the protocols of manufacturers (“Milliplex MAP Kit”, Merck Millipore, USA). All statistical analyses were performed in the GraphPad Prism version 8.3.0 (GraphPad Software, USA).

Results

ogistic regression analysis made it possible to identify cytokines associated with the distant metastases. Thus, in patients who did not receive NACT, high concentrations of IL-6 and CXCL-12 (SDF-1) and the histological type of tumor (squamous cell carcinoma) were associated with a high risk of distant metastases (χ2 = 15.7; p = 0.0013). In patients after NACT a high concentration of IL-4 and a histological type of tumor (adenocarcinoma) were associated with a high risk of distant metastases (χ2 = 10.7; p = 0.0047).

Conclusions

The concentration of serum cytokines involved in inflammation and the formation of the premetastatic niche varies in patients with NSCLC. A high risk of the distant metastases is associated with high concentrations of IL-6, CXCL-12 (SDF-1) and IL-4 and histological type of NSCLC. Also, it is necessary to remember that the NACT in some cases promotes the distant metastases.

Legal entity responsible for the study

The authors.

Funding

The Council for Grants of President of Russian Federation (Grant SS-2701.2020.7).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.